Most Favored Patient Act of 2026

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7837 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7837 To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model implementing most- favored-nation drug pricing. _______________________________________________________________________ March 5, 2026 Mr. Meuser introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model implementing most- favored-nation drug pricing. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Most Favored Patient Act of 2026''. SEC. 2. REQUIRING THE CENTER FOR MEDICARE AND MEDICAID INNOVATION TO TEST A MODEL IMPLEMENTING MOST FAVORED NATION DRUG PRICING. Section 1115A of the Social Security Act (42 U.S.C. 1315a) is amended-- (1) in subsection (b)(2)(A), by inserting ``, and, beginning January 1, 2029, shall include the Most Favored Nations Pricing Model described in subsection (h)'' before the period at the end; and (2) by adding at the end the following new subsection: ``(h) Most Favored Nations Pricing Model.-- ``(1) In general.--For purposes of subsection (b)(2)(A), the Most Favored Nations Pricing Model described in this subsection is a model under which, subject to paragraph (2), each specified manufacturer-- ``(A) provides access to the most-favored-nation price of each covered drug of such manufacturer-- ``(i) to most